dc.contributor.author
An, Nguyen Ngoc
dc.contributor.author
Tung, Dao Quang
dc.contributor.author
Van Tue, Le
dc.contributor.author
Son, Nguyen Thanh
dc.contributor.author
Tung, Nguyen Thanh
dc.contributor.author
Le, Huong-Giang
dc.contributor.author
Tam, Thai Chinh
dc.contributor.author
Thuan, Nguyen Thị
dc.contributor.author
Baecker, Daniel
dc.contributor.author
Dung, Do Thi Mai
dc.date.accessioned
2025-12-18T06:47:22Z
dc.date.available
2025-12-18T06:47:22Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/50872
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-50599
dc.description.abstract
Pharmacological studies revealed that the Balanophora species contains diverse phytochemicals which enable interesting biological activities and emphasize their pharmaceutical relevance. Previously, we identified significant xanthine oxidase (XO) inhibitory activity from extracts of the two Balanophora spp. ( Balanophora subcupularis P.C. Tam and Balanophora tobiracola Makino). However, the specific compounds responsible for this activity remain unidentified so far. Thus, in the present study, we focused on elucidating the compounds inducing the XO inhibitory effect of extracts from Balanophora species. Therefore, a combination of advanced liquid chromatography and mass spectrometry (LC-QToF-HRMS), virtual screening using machine learning (ML) models, and molecular docking simulation was applied. Using LC-QToF-HRMS, 23 and 21 compounds were identified in the ethyl acetate fractions of B. subcupularis and B. tobiracola , respectively. Next, a curated dataset of natural and synthetic compounds with known XO inhibitory activity was employed to train several ML models. Adducing five selected ML models, the virtual screening process identified the potentially active compounds 1-(3,4-dihydroxyphenyl)-6,7-dihydroxy-1,2-dihydro-2,3-naphthalenedicarboxylic acid, taxifolin, and 1- O -caffeoyl-6- O -(S)-brevifolincarboxyl- β -D-glucopyranose. All the compounds found in the two Balanophora spp. underwent docking simulations, in which MTE, FES, and AFH were retained in the active site of XO, ensuring reliable re-docking results. Finally, taxifolin emerged as the most promising novel XO inhibitor, demonstrating greater potential than the established drug allopurinol, as supported by both the virtual screening nomination and docking simuation. These findings contribute to the development of natural XO inhibitors and may open new opportunities for gout treatment and uric acid level control.
en
dc.format.extent
18 Seiten
dc.rights
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Balanophora species
en
dc.subject
Xanthine oxidase inhibitors
en
dc.subject
Machine learning
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::540 Chemie::540 Chemie und zugeordnete Wissenschaften
dc.title
Unveiling potent xanthine oxidase inhibitors in two Balanophora spp. using machine learning-based virtual screening and molecular docking approach
dc.type
Wissenschaftlicher Artikel
dc.date.updated
2025-12-17T18:32:48Z
dcterms.bibliographicCitation.articlenumber
43877
dcterms.bibliographicCitation.doi
10.1038/s41598-025-32282-6
dcterms.bibliographicCitation.journaltitle
Scientific Reports
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.volume
15
dcterms.bibliographicCitation.url
https://doi.org/10.1038/s41598-025-32282-6
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Pharmazie

refubium.funding
Springer Nature DEAL
refubium.note.author
Gefördert aus Open-Access-Mitteln der Freien Universität Berlin.
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
2045-2322
refubium.resourceType.provider
DeepGreen